- Home
- GFAI vs MIRA Comparison
GFAI vs MIRA Comparison
Compare GFAI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- MIRA
- Stock Information
- Founded
- GFAI 2018
- MIRA 2020
- Country
- GFAI Singapore
- MIRA United States
- Employees
- GFAI N/A
- MIRA N/A
- Industry
- GFAI Diversified Commercial Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- MIRA Health Care
- Exchange
- GFAI Nasdaq
- MIRA Nasdaq
- Market Cap
- GFAI 20.7M
- MIRA 19.5M
- IPO Year
- GFAI N/A
- MIRA 2023
- Fundamental
- Price
- GFAI $1.15
- MIRA $1.35
- Analyst Decision
- GFAI Strong Buy
- MIRA Strong Buy
- Analyst Count
- GFAI 1
- MIRA 2
- Target Price
- GFAI $4.50
- MIRA $14.00
- AVG Volume (30 Days)
- GFAI 367.3K
- MIRA 684.0K
- Earning Date
- GFAI 04-28-2025
- MIRA 05-14-2025
- Dividend Yield
- GFAI N/A
- MIRA N/A
- EPS Growth
- GFAI N/A
- MIRA N/A
- EPS
- GFAI N/A
- MIRA N/A
- Revenue
- GFAI $36,347,373.00
- MIRA N/A
- Revenue This Year
- GFAI $5.66
- MIRA N/A
- Revenue Next Year
- GFAI $4.69
- MIRA N/A
- P/E Ratio
- GFAI N/A
- MIRA N/A
- Revenue Growth
- GFAI 0.18
- MIRA N/A
- 52 Week Low
- GFAI $0.76
- MIRA $0.51
- 52 Week High
- GFAI $3.88
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- GFAI 53.79
- MIRA 60.88
- Support Level
- GFAI $1.11
- MIRA $1.14
- Resistance Level
- GFAI $1.33
- MIRA $1.43
- Average True Range (ATR)
- GFAI 0.08
- MIRA 0.11
- MACD
- GFAI 0.01
- MIRA -0.00
- Stochastic Oscillator
- GFAI 37.93
- MIRA 53.85
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.